Shopping Cart
Remove All
Your shopping cart is currently empty
LSD1/HDAC6-IN-2 (JBI-802) is an orally active inhibitor of LSD1/HDAC6/HDAC8 with IC₅₀ values of 50 nM, 11 nM, and 98 nM respectively, exhibiting good selectivity towards MAOs. JBI-802 demonstrates antiproliferative activity against multiple cell lines including AML, CLL, and SCLC, inhibiting tumour growth.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,930 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,610 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,330 | 10-14 weeks | 10-14 weeks |
| Description | LSD1/HDAC6-IN-2 (JBI-802) is an orally active inhibitor of LSD1/HDAC6/HDAC8 with IC₅₀ values of 50 nM, 11 nM, and 98 nM respectively, exhibiting good selectivity towards MAOs. JBI-802 demonstrates antiproliferative activity against multiple cell lines including AML, CLL, and SCLC, inhibiting tumour growth. |
| Targets&IC50 | MAO-A:5 nM, LSD1:5 nM, HDAC6:11 nM, MAO-B:6600 nM |
| In vitro | LSD1/HDAC6-IN-2 (JBI-802) exhibits growth inhibitory activity against multiple myeloma cells MM.1S, MM.1R, and RPMI-8226, with EC50 values of 2 nM, 6 nM, and 280 nM, respectively [1]. |
| In vivo | LSD1/HDAC6-IN-2 (JBI-802), administered orally at a dosage of 25 mg/kg once daily for 12 days, exhibits antitumor activity in a mouse model of multiple myeloma [1]. |
| Molecular Weight | 443.34 |
| Formula | C21H23BrN4O2 |
| Cas No. | 2982787-50-6 |
| Smiles | N(CC1=CN(CC2=CC=C(C(NO)=O)C=C2)N=C1)[C@H]3[C@@H](C3)C4=CC=CC=C4.Br |
| Color | White |
| Appearance | Solid |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: ≥ 80 mg/mL, Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.